A phase i dose-escalation study of edotecarin (J-107088) combined with infusional 5-fluorouracil and leucovorin in patients with advanced/metastatic solid tumors

Muhammad Wasif Saif, Sandra Sellers, Robert B. Diasio, Jean Yves Douillard

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A phase i dose-escalation study of edotecarin (J-107088) combined with infusional 5-fluorouracil and leucovorin in patients with advanced/metastatic solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences